• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation.通过生物共轭将 siRNA 靶向递送至肝细胞和肝星状细胞。
Bioconjug Chem. 2010 Nov 17;21(11):2119-27. doi: 10.1021/bc100346n. Epub 2010 Oct 21.
2
Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro.体外通过半乳糖化聚乙二醇接枝聚亚乙基亚胺实现肝细胞靶向 psiRNA 递呈。
J Biomater Appl. 2011 Sep;26(3):255-75. doi: 10.1177/0885328210364678. Epub 2010 May 28.
3
Chemically defined polyethylene glycol siRNA conjugates with enhanced gene silencing effect.具有增强基因沉默效果的化学定义的聚乙二醇化小干扰RNA缀合物。
Bioorg Med Chem. 2014 Apr 1;22(7):2320-6. doi: 10.1016/j.bmc.2014.02.004. Epub 2014 Feb 20.
4
Dicer-labile PEG conjugates for siRNA delivery.Dicer 敏感性 PEG 缀合物用于 siRNA 递呈。
Biomacromolecules. 2011 Dec 12;12(12):4301-10. doi: 10.1021/bm201199c. Epub 2011 Nov 21.
5
TGF-beta1 gene silencing for treating liver fibrosis.转化生长因子-β1基因沉默治疗肝纤维化
Mol Pharm. 2009 May-Jun;6(3):772-9. doi: 10.1021/mp9000469.
6
Gene silencing efficiency of siRNA-PEG conjugates: effect of PEGylation site and PEG molecular weight.siRNA-PEG 缀合物的基因沉默效率:PEG 化位点和 PEG 分子量的影响。
J Control Release. 2010 Jun 15;144(3):306-13. doi: 10.1016/j.jconrel.2010.03.002. Epub 2010 Mar 4.
7
A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes.一种用于向肝细胞进行基因递送的半乳糖-聚(乙二醇)-聚乙烯亚胺的新合成方法。
J Control Release. 2002 Feb 19;79(1-3):271-81. doi: 10.1016/s0168-3659(01)00555-7.
8
Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.阳离子胆固醇衍生物脂质体介导的小干扰 RNA 递送至肝脏。
J Liposome Res. 2017 Dec;27(4):264-273. doi: 10.1080/08982104.2016.1205599. Epub 2016 Jul 21.
9
TGF-β1 and FOXM1 siRNA co-loaded nanoparticles by disulfide crosslinked PEG-PDMAEMA for the treatment of triple-negative breast cancer and its bone metastases in vitro.通过二硫键交联的聚乙二醇-聚甲基丙烯酸二甲氨基乙酯共负载转化生长因子-β1和叉头框蛋白M1小干扰RNA的纳米颗粒用于体外治疗三阴性乳腺癌及其骨转移
Drug Dev Ind Pharm. 2024 Sep;50(9):777-788. doi: 10.1080/03639045.2024.2404979. Epub 2024 Sep 25.
10
Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.由两阶段聚乙二醇化步骤组成的长循环阳离子纳米颗粒制剂的表征,用于在乳腺癌肿瘤模型中递送 siRNA。
J Pharm Sci. 2013 Jan;102(1):227-36. doi: 10.1002/jps.23351. Epub 2012 Nov 6.

引用本文的文献

1
Navigating liver cancer: Precision targeting for enhanced treatment outcomes.应对肝癌:精准靶向治疗以提高治疗效果。
Drug Deliv Transl Res. 2025 Jun;15(6):1935-1961. doi: 10.1007/s13346-024-01780-x. Epub 2025 Jan 23.
2
Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis.肝星状细胞中的乳酸转运蛋白 MCT1 促进非酒精性脂肪性肝炎中的纤维性胶原表达。
Elife. 2024 Apr 2;12:RP89136. doi: 10.7554/eLife.89136.
3
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies.糖基化影响多种蛋白、基因和细胞治疗的疗效和安全性。
Biotechnol Adv. 2023 Oct;67:108206. doi: 10.1016/j.biotechadv.2023.108206. Epub 2023 Jun 22.
4
Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis.肝星状细胞中的乳酸转运体MCT1促进非酒精性脂肪性肝炎中纤维化胶原蛋白的表达。
bioRxiv. 2023 Oct 19:2023.05.03.539244. doi: 10.1101/2023.05.03.539244.
5
Evolution of complexity in non-viral oligonucleotide delivery systems: from gymnotic delivery through bioconjugates to biomimetic nanoparticles.非病毒寡核苷酸递药系统复杂性的演变:从巧妙递药到生物缀合物再到仿生纳米颗粒。
RNA Biol. 2022 Jan;19(1):1256-1275. doi: 10.1080/15476286.2022.2147278.
6
PK-modifying anchors significantly alter clearance kinetics, tissue distribution, and efficacy of therapeutics siRNAs.PK修饰性锚定物可显著改变治疗性小干扰RNA的清除动力学、组织分布及疗效。
Mol Ther Nucleic Acids. 2022 Jun 13;29:116-132. doi: 10.1016/j.omtn.2022.06.005. eCollection 2022 Sep 13.
7
Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis.糖尿病相关非酒精性脂肪性肝病和肝纤维化的治疗靶点、新型药物及给药系统
Adv Drug Deliv Rev. 2021 Sep;176:113888. doi: 10.1016/j.addr.2021.113888. Epub 2021 Jul 24.
8
Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide.通过细胞内化SELEX获得的碱基修饰适配体促进反义寡核苷酸的细胞摄取。
Mol Ther Nucleic Acids. 2020 Nov 26;23:440-449. doi: 10.1016/j.omtn.2020.11.016. eCollection 2021 Mar 5.
9
Molecular Mechanism for Selective Cytotoxicity towards Cancer Cells of Diselenide-Containing Paclitaxel Nanoparticles.含二硒键紫杉醇纳米粒子对癌细胞选择性细胞毒性的分子机制。
Int J Biol Sci. 2019 Jul 3;15(8):1755-1770. doi: 10.7150/ijbs.34878. eCollection 2019.
10
Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery.siRNA 生物缀合物在体外和体内递送上的当前方面。
Molecules. 2019 Jun 13;24(12):2211. doi: 10.3390/molecules24122211.

本文引用的文献

1
Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands.通过与小分子配体缀合实现反义寡核苷酸的靶向细胞内递送。
J Am Chem Soc. 2010 Jul 7;132(26):8848-9. doi: 10.1021/ja102635c.
2
Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.利用螯合剂脂质锚定分子将隐形小干扰RNA脂质复合物便捷地靶向细胞。
J Control Release. 2009 Nov 3;139(3):229-38. doi: 10.1016/j.jconrel.2009.06.034. Epub 2009 Jul 10.
3
siRNA delivery systems for cancer treatment.用于癌症治疗的小干扰RNA递送系统。
Adv Drug Deliv Rev. 2009 Aug 10;61(10):850-62. doi: 10.1016/j.addr.2009.04.018. Epub 2009 May 5.
4
TGF-beta1 gene silencing for treating liver fibrosis.转化生长因子-β1基因沉默治疗肝纤维化
Mol Pharm. 2009 May-Jun;6(3):772-9. doi: 10.1021/mp9000469.
5
Penetration and efficacy of VEGF siRNA using polyelectrolyte complex micelles in a human solid tumor model in-vitro.聚电解质复合胶束包裹的VEGF siRNA在人实体瘤体外模型中的穿透性及疗效
J Control Release. 2009 Jul 20;137(2):130-5. doi: 10.1016/j.jconrel.2009.03.009. Epub 2009 Mar 21.
6
siRNA conjugate delivery systems.小干扰RNA缀合物递送系统
Bioconjug Chem. 2009 Jan;20(1):5-14. doi: 10.1021/bc800278e.
7
Structural and formulation factors influencing pyridinium lipid-based gene transfer.影响基于吡啶鎓脂质的基因转移的结构和制剂因素。
Bioconjug Chem. 2008 Dec;19(12):2499-512. doi: 10.1021/bc8004039.
8
Detection and relative quantification of siRNA double strands by MALDI mass spectrometry.利用基质辅助激光解吸电离质谱法检测和相对定量小干扰RNA双链体
Anal Chem. 2008 Aug 15;80(16):6280-5. doi: 10.1021/ac800605z. Epub 2008 Jul 11.
9
Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer.使用聚电解质复合胶束进行VEGF小干扰RNA的局部和全身递送以有效治疗癌症。
J Control Release. 2008 Jul 14;129(2):107-16. doi: 10.1016/j.jconrel.2008.03.008. Epub 2008 Mar 14.
10
Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol.通过α-生育酚偶联实现siRNA在体内向肝脏的高效递送。
Mol Ther. 2008 Apr;16(4):734-40. doi: 10.1038/mt.2008.14. Epub 2008 Feb 12.

通过生物共轭将 siRNA 靶向递送至肝细胞和肝星状细胞。

Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation.

机构信息

Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 38103, United States.

出版信息

Bioconjug Chem. 2010 Nov 17;21(11):2119-27. doi: 10.1021/bc100346n. Epub 2010 Oct 21.

DOI:10.1021/bc100346n
PMID:20964335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2998752/
Abstract

Previously, we successfully conjugated galactosylated poly(ethylene glycol) (Gal-PEG) to oligonucleotides (ODNs) via an acid labile ester linker (Zhu et al., Bioconjugate Chem. 2008, 19, 290-8). In this study, sense strands of siRNA were conjugated to Gal-PEG and mannose 6-phosphate poly(ethylene glycol) (M6P-PEG) for targeted delivery of siRNAs to hepatocytes and hepatic stellate cells (HSCs), respectively. These siRNA conjugates were purified by ion exchange chromatography and verified by gel retardation assay. To evaluate their RNAi functions, the validated siRNA duplexes targeting firefly luciferase and transforming growth factor beta 1 (TGF-β1) mRNA were conjugated to Gal-PEG and M6P-PEG, and their gene silencing efficiencies were determined after transfection into HepG2 and HSC-T6 cells. The disulfide bond between PEG and siRNA was cleaved by dithiothreitol, leading to the release of intact siRNA. Both Gal-PEG-siRNA and M6P-PEG-siRNA conjugates could silence luciferase gene expression by about 40% without any transfection reagents, while the gene silencing effects reached more than 98% with the help of cationic liposomes at the same dose. Conjugation of TGF-β1 siRNA with Gal-PEG and M6P-PEG could silence endogenous TGF-β1 gene expression as well. In conclusion, these siRNA conjugates have the potential for targeted delivery of siRNAs to hepatocytes and hepatic stellate cells for efficient gene silencing in vivo.

摘要

此前,我们通过酸不稳定酯键成功地将半乳糖化聚乙二醇(Gal-PEG)与寡核苷酸(ODNs)偶联(Zhu 等人,生物共轭化学。2008 年,19,290-8)。在这项研究中,siRNA 的正义链与 Gal-PEG 和甘露糖 6-磷酸聚乙二醇(M6P-PEG)偶联,分别用于将 siRNA 靶向递送至肝细胞和肝星状细胞(HSCs)。这些 siRNA 缀合物通过离子交换色谱法纯化,并通过凝胶阻滞试验验证。为了评估它们的 RNAi 功能,针对萤火虫荧光素酶和转化生长因子 β1(TGF-β1)mRNA 的验证 siRNA 双链体与 Gal-PEG 和 M6P-PEG 偶联,并在转染 HepG2 和 HSC-T6 细胞后测定其基因沉默效率。PEG 和 siRNA 之间的二硫键被二硫苏糖醇切割,导致完整的 siRNA 释放。Gal-PEG-siRNA 和 M6P-PEG-siRNA 缀合物在没有任何转染试剂的情况下,均可将荧光素酶基因表达沉默约 40%,而在相同剂量下,阳离子脂质体的帮助下,基因沉默效果达到 98%以上。TGF-β1 siRNA 与 Gal-PEG 和 M6P-PEG 的偶联也可以沉默内源性 TGF-β1 基因表达。总之,这些 siRNA 缀合物具有将 siRNA 靶向递送至肝细胞和肝星状细胞的潜力,可在体内实现高效基因沉默。